(Q43241602)

17 November 2017

title

Changes in expression, and/or mutations in TGF-beta receptors (TGF-beta RI and TGF-beta RII) and Smad 4 in human ovarian tumors (English)

1 reference

17 November 2017

Marie Lue Antony

1

1 reference

17 November 2017

Rema Nair

series ordinal

2

1 reference

17 November 2017

Paul Sebastian

series ordinal

3

1 reference

17 November 2017

Devarajan Karunagaran

series ordinal

4

1 reference

17 November 2017

publication date

1 March 2010

1 reference

Journal of Cancer Research and Clinical Oncology

17 November 2017

published in

1 reference

17 November 2017

volume

136

1 reference

17 November 2017

issue

3

1 reference

17 November 2017

page(s)

351-361

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-009-0703-4

17 November 2017

exact match

0 references

cites work

Bmi1 is required for Hedgehog pathway-driven medulloblastoma expansion

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0703-4

Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk

21 January 2018

1 reference

12 December 2020

A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma.

1 reference

12 December 2020

TbetaR-I(6A) is a candidate tumor susceptibility allele

1 reference

12 December 2020

NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix

1 reference

12 December 2020

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

1 reference

12 December 2020

Roles of TGFbeta in metastasis

1 reference

12 December 2020

Null mutation in transforming growth factor beta1 disrupts ovarian function and causes oocyte incompetence and early embryo arrest

1 reference

12 December 2020

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

1 reference

12 December 2020

Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines

1 reference

12 December 2020

Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors

1 reference

12 December 2020

Global cancer statistics, 2002

1 reference

12 December 2020

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

1 reference

12 December 2020

TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies

1 reference

12 December 2020

A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability

1 reference

12 December 2020

Comparison of the quantitative competitive and semiquantitative RT-PCR methods for the determination of interferon-gamma mRNA levels in AIDS-free HIV-infected individuals

1 reference

12 December 2020

Expression of p53, p21WAF1/CIP1, p16INK4A and Ki-67 proteins in serous ovarian tumors

1 reference

12 December 2020

Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells

1 reference

12 December 2020

Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition

1 reference

12 December 2020

Cell cycle genes in ovarian cancer: steps toward earlier diagnosis and novel therapies

1 reference

12 December 2020

TGFBR1*6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation

1 reference

12 December 2020

Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors

1 reference

12 December 2020

Prognostic significance and correlation with survival of bcl-2 and TGF-beta RII in colon cancer

1 reference

12 December 2020

Prognostic significance of TGF beta 1 and TGF beta 3 in human breast carcinoma.

1 reference

12 December 2020

Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.

1 reference

12 December 2020

Genetic models for transforming growth factor beta superfamily signaling in ovarian follicle development

1 reference

12 December 2020

Microsatellite instability in synchronous gastric carcinomas.

1 reference

12 December 2020

P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens.

1 reference

12 December 2020

Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors

1 reference

12 December 2020

Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas.

1 reference

12 December 2020

Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer

1 reference

12 December 2020

Somatic acquisition and signaling of TGFBR1*6A in cancer

1 reference

12 December 2020

Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta

1 reference

12 December 2020

Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer.

1 reference

12 December 2020

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

1 reference

12 December 2020

Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling

1 reference

12 December 2020

How the Smads regulate transcription

1 reference

12 December 2020

Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma

1 reference

12 December 2020

Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses

1 reference

12 December 2020

The anticancer agent prodigiosin induces p21WAF1/CIP1 expression via transforming growth factor-beta receptor pathway

1 reference

12 December 2020

Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling via the Smad pathway

1 reference

12 December 2020

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

12 December 2020

Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development

1 reference

12 December 2020

Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer

1 reference

12 December 2020

DPC4 gene in various tumor types

1 reference

12 December 2020

Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer

1 reference

12 December 2020

The logic of TGFbeta signaling.

1 reference

12 December 2020

Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.

1 reference

12 December 2020

Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas.

1 reference

12 December 2020

Determinants of specificity in TGF-beta signal transduction.

1 reference

12 December 2020

Lost in transcription: p21 repression, mechanisms, and consequences

1 reference

12 December 2020

Differential activation of Smads in HeLa and SiHa cells that differ in their response to transforming growth factor-beta

1 reference

12 December 2020

10.1007/S00432-009-0703-4

Identifiers

DOI

1 reference

17 November 2017

1 reference